|
0
|
|
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.
(journals.asm.org)
|
Joisten CS
…
Stemler J
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#pharmacokinetics
#toxicity
#drug-drug interaction
#leukemia
|
|
0
|
|
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.
(journals.asm.org)
|
Cornelissen K
…
Bruggemann R
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#pharmacokinetics
#modeling
#antifungal
#drug-drug interaction
|
|
0
|
|
Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease.
(academic.oup.com)
|
Rodgers MP
…
Aarnoutse RE
Journal of Antimicrobial Chemotherapy
2026-06-03
|
#pharmacokinetics
#infection
#therapeutics
#drug-drug interaction
|
|
0
|
|
Pharmacokinetic drug-drug interaction between the COVID-19 3CL protease inhibitor GST-HG171 and itraconazole in healthy subjects.
(journals.asm.org)
|
Li X
…
Ding Y
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#pharmacokinetics
#covid-19
#drug-drug interaction
#protease inhibitor
|